Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell

Cancer Letters

Volumn 271, Issue 2, 2008, Pages 281-293

  Yang, Xiaojun ^a   Zhang, Youcheng ^a   Zhang, Lingyi ^a   Zhang, Lin ^a   Mao, Jie ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

AFP; Apoptosis; Cytochrome c; Hepatocellular carcinoma; RNA interference

Indexed keywords

ALPHA FETOPROTEIN; CASPASE 3; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-FETOPROTEINS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 53249140333     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.017     Document Type: Article

References (47)

1. Bruix J., Boix L., Sala M., and Llovet J.M. Focus on hepatocellular carcinoma. Cancer Cell 5 3 (2004) 215-219
2. Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., and Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. (2007) 2713-2722
3. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31 4 (2002) 339-346
4. Nakabayashi H., Hashimoto T., Miyao Y., Tjong K.K., Chan J., and Tamaoki T. A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol. Cell. Biol. 11 12 (1991) 5885-5893
5. Deutsch H.F. Chemistry and biology of alpha-fetoprotein. Adv. Cancer Res. 56 (1991) 253-312
6. Toder V., Blank M., Gold-Gefter L., and Nebel L. The effect of alpha-fetoprotein on the growth of placental cells in vitro. Placenta 4 1 (1983) 79-86
7. Mizejewski G.J., Keenan J.F., and Setty R.P. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid. Biol. Reprod. 42 5-6 (1990) 887-898
8. Bennett J.A., Zhu S., Pagano-Mirarchi A., Kellom T.A., and Jacobson H.I. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin. Cancer Res. 4 11 (1998) 2877-2884
9. Dudich E., Semenkova L., Gorbatova E., Dudich I., Khromykh L., Tatulov E., Grechko G., and Sukhikh G. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol. 19 1 (1998) 30-40
10. Dudich E.I., Semenkova L.N., Dudich I.V., Nikolaeva M.A., Gorbatova E.A., Khromykh L.M., Grechko G.K., and Sukhikh G.T. alpha-Fetoprotein-induced apoptosis of cancer cells. Bull. Exp. Biol. Med. 130 12 (2000) 1127-1133
11. Wang Y.S., Ma X.L., Qi T.G., Liu X.D., Meng Y.S., and Guan G.J. Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells. World J. Gastroenterol. 11 38 (2005) 6053-6055
12. Li M.S., Li P.F., He S.P., Du G.G., and Li G. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J. Gastroenterol. 8 3 (2002) 469-475
13. Mizejewski G.J. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp. Biol. Med. (Maywood) 226 5 (2001) 377-408
14. Grishok A., Tabara H., and Mello C.C. Genetic requirements for inheritance of RNAi in C. elegans. Science 287 5462 (2000) 2494-2497
15. Harborth J., Elbashir S.M., Bechert K., Tuschl T., and Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114 Pt. 24 (2001) 4557-4565
16. Yu J.Y., DeRuiter S.L., and Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99 9 (2002) 6047-6052
17. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 3 (2004) 326-330
18. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., and Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 2 (2003) 199-208
19. Araki T., Yamamoto A., and Yamada M. Accurate determination of DNA content in single cell nuclei stained with Hoechst 33258 fluorochrome at high salt concentration. Histochemistry 87 4 (1987) 331-338
20. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184 1 (1995) 39-51
21. Finlay C.A., Hinds P.W., Tan T.H., Eliyahu D., Oren M., and Levine A.J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol. 8 2 (1988) 531-539
22. Mizejewski G.J. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev. Anticancer Ther. 2 6 (2002) 709-735
23. De Mees C., Laes J.F., Bakker J., Smitz J., Hennuy B., Van Vooren P., Gabant P., Szpirer J., and Szpirer C. Alpha-fetoprotein controls female fertility and prenatal development of the gonadotropin-releasing hormone pathway through an antiestrogenic action. Mol. Cell. Biol. 26 5 (2006) 2012-2018
24. Bakker J., De Mees C., Douhard Q., Balthazart J., Gabant P., Szpirer J., and Szpirer C. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat. Neurosci. 9 2 (2006) 220-226
25. Laderoute M.P., and Pilarski L.M. The inhibition of apoptosis by alpha-fetoprotein (AFP) and the role of AFP receptors in anti-cellular senescence. Anticancer Res. 14 6B (1994) 2429-2438
26. Goldstein N.S., Blue D.E., Hankin R., Hunter S., Bayati N., Silverman A.L., and Gordon S.C. Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores. Am. J. Clin. Pathol. 111 6 (1999) 811-816
27. Semenkova L.N., Dudich E.I., Dudich I.V., Shingarova L.N., and Korobko V.G. Alpha-fetoprotein as a TNF resistance factor for the human hepatocarcinoma cell line HepG2. Tumour Biol. 18 1 (1997) 30-40
28. Dudich E., Semenkova L., Dudich I., Gorbatova E., Tochtamisheva N., Tatulov E., Nikolaeva M., and Sukhikh G. Alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases. Eur. J. Biochem. 266 3 (1999) 750-761
29. Semenkova L., Dudich E., Dudich I., Tokhtamisheva N., Tatulov E., Okruzhnov Y., Garcia-Foncillas J., Palop-Cubillo J.A., and Korpela T. Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation. Eur. J. Biochem. 270 21 (2003) 4388-4399
30. Semenkova L.N., Dudich E.I., and Dudich I.V. Induction of apoptosis in human hepatoma cells by alpha-fetoprotein. Tumour Biol. 18 5 (1997) 261-273
31. Wang X.W., and Xie H. Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci. 64 1 (1999) 17-23
32. Dudich I., Tokhtamysheva N., Semenkova L., Dudich E., Hellman J., and Korpela T. Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein. Biochemistry 38 32 (1999) 10406-10414
33. Li M.S., Ma Q.L., Chen Q., Liu X.H., Li P.F., Du G.G., and Li G. Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells. World J. Gastroenterol. 11 17 (2005) 2564-2569
34. Li M.S., Li P.F., Chen Q., Du G.G., and Li G. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World J. Gastroenterol. 10 6 (2004) 819-824
35. Matsumoto Y., Suzuki T., Asada I., Ozawa K., Tobe T., and Honjo I. Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer 49 2 (1982) 354-360
36. Konnikova L., Kotecki M., Kruger M.M., and Cochran B.H. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3 (2003) 23
37. Tuschl T., and Borkhardt A. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol. Interv. 2 3 (2002) 158-167
38. Zhang X.W., and Xu B. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. Anticancer Drugs 11 9 (2000) 747-756
39. Caruso M.L., and Valentini A.M. Overexpression of p53 in a large series of patients with hepatocellular carcinoma: a clinicopathological correlation. Anticancer Res. 19 5B (1999) 3853-3856
40. Wilkinson D.S., Ogden S.K., Stratton S.A., Piechan J.L., Nguyen T.T., Smulian G.A., and Barton M.C. A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol. Cell. Biol. 25 3 (2005) 1200-1212
41. Lee K.C., Crowe A.J., and Barton M.C. p53-Mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol. Cell. Biol. 19 2 (1999) 1279-1288
42. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 2 (1995) 293-299
43. von Freeden-Jeffry U., Solvason N., Howard M., and Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7 1 (1997) 147-154
44. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., and Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 6 (1994) 1799-1805
45. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124 1-2 (1994) 1-6
46. Yasuhara N., Sahara S., Kamada S., Eguchi Y., and Tsujimoto Y. Evidence against a functional site for Bcl-2 downstream of caspase cascade in preventing apoptosis. Oncogene 15 16 (1997) 1921-1928
47. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., and Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 3 (2002) 331-342